Direxion Daily S&P Biotech Bear 3X ETF
LABD
8 hedge funds and large institutions have $20.5M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 8 closing their positions.
36% more call options, than puts
Call options by funds: $6.83M | Put options by funds: $5.01M
0.07% more ownership
Funds ownership: 0.12% → 0.19% (+0.07%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
43% less funds holding
Funds holding: 14 → 8 (-6)
55% less capital invested
Capital invested by funds: $45.5M → $20.5M (-$25M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$765K |
| 2 |
Wolverine Trading
Chicago,
Illinois
|
+$616K |
| 3 |
Citigroup
New York
|
+$331K |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$220K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$8.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$23.3M |
| 2 |
IMC Chicago
Chicago,
Illinois
|
-$3.45M |
| 3 |
HF
HRT Financial
New York
|
-$2.15M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.27M |
| 5 |
Morgan Stanley
New York
|
-$722K |
LABD Hedge Fund Activity: Q1 2020 in Review
8 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q1 2020, worth a combined $20.5M — down 55% from $45.5M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LABD and 3 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $765K. The largest seller was Boxer Capital, cutting an estimated $23.3M.
- 8 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q1 2020, down from 14 in Q4 2019.
- Funds reported $20.5M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q1 2020, down 55% quarter-over-quarter.
- 3 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q1 2020 and 8 closed out, a net change of -5 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q1 2020 was Citadel Advisors, an estimated $765K added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q1 2020 was Boxer Capital, an estimated $23.3M sold.
Based on aggregated 13F filings for Q1 2020.